[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338177-105":59,"doc-detail-338177-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-a-prognostic-signature-of-breast-cancer-based-on-drug-absorption-distribution-metabolism-and-excretion-adme-related-genes","Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes","","Individual differences in carcinogenesis and drug response are shaped by drugs’ absorption, distribution, metabolism, and excretion (ADME). Signatures derived from ADME-related genes are proposed to predict prognosis and treatment response across cancer types, but their roles in breast cancer need clarification. Using LASSO regression on prognostic differentially expressed genes from tumor and normal tissues, a four-gene ADME signature was constructed, validated with RT-qPCR, and integrated into a nomogram for improved clinical utility. The low-risk group showed higher immune scores and distinct immune cell and immune gene patterns, supporting ADME signatures as biomarkers for individualized treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-a-prognostic-signature-of-breast-cancer-based-on-drug-absorption-distribution-metabolism-and-excretion-adme-related-genes/338177/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-a-prognostic-signature-of-breast-cancer-based-on-drug-absorption-distribution-metabolism-and-excretion-adme-related-genes/338177.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological process does the ADME prognostic signature focus on?","Question",{"text":112,"@type":113},"It is built on genes involved in drug absorption, distribution, metabolism, and excretion (ADME), reflecting how drug pharmacokinetics may relate to cancer prognosis and response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic signature constructed and validated?",{"text":117,"@type":113},"The signature was constructed using a least absolute shrinkage and selection operator (LASSO) model on prognostic differentially expressed genes from both cancer tissue and normal tissue, then validated through robustness analyses with RT-qPCR for risk-related gene expression.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical tool was developed from the ADME signature?",{"text":121,"@type":113},"A nomogram was developed by combining clinicopathological characteristics with the four-gene ADME signature to improve clinical utility and predictive performance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338177,1790467530,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDevelopment and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes  \nZhixuan Wu2, Yangyang Guo2, Liangchen Qu3, Xiaowu Wang4 & Hewei Zhang1,5􀀍  \nThe individual variation of carcinogenesis and drug response is influenced by the absorption, distribution, metabolism, and excretion (ADME) of drugs. The utilization of signatures derived from ADME-related genes holds potential for predicting prognosis and treatment response across diverse cancer types. Further investigation is required to completely understand the role ofADMEassociated genes in breast cancer. A signature was constructed through the application of a least absolute shrinkage and selection operator regression model, employing prognostic differentially expressed genes found in both cancer tissue and normal tissue. To assess the robustness of the signature, verification analyses were carried out. RT-qPCR was utilized for the validation of gene expression related to risk. Subsequently, a nomogram was developed to enhance the clinical utility of our prognostic tool. TheADME signature, comprising four genes, was established and exhibited a robust association with the prognoses of individuals diagnosed with breast cancer. The nomogram was created by fusing the clinicopathological characteristics with theADME signature. TheADME signature demonstrated remarkable superiority when compared to the performance of the other individual predictors. Additionally, the analysis of the immune microenvironment revealed that the ImmuneScores ofthe low-risk group were elevated. The variation in both the infiltration of immune cells and the expression of immune-related genes in the tissues differed among the two groups. For patients with breast cancer, the utilization of ADME signatures as biomarkers presents a significant reference point for prognosis and individualized treatment strategies.  \nKeywords ADME, Breast cancer, Immune microenvironment, Immunotherapy, Prognosis  \nBreast cancer is acknowledged as a prevalent malignancy that impacts women on a global scale, with an increasing incidence rate documented each year1–3. The disease is characterized by a high degree of heterogeneity, resulting in variations in clinical presentation, morphology, molecular profile, treatment response, and prognosis among individual cases4,5. Clinically, tumor stage, histological grade and molecular subtype are commonly used as prognostic indicators for breast cancer patients6. However, accurate prediction of patient prognosis based on clinicopathological characteristics remains challenging. This limitation may result in misjudgments of prognosis, potentially leading to inappropriate treatment decisions that could increase the risk of metastasis or recurrence in high-risk patients and unnecessary or overly aggressive treatment in low-risk patients7. In order to optimize patient treatment for individuals diagnosed with breast cancer, it is imperative to identify innovative molecular markers that can reliably predict the prognosis.  \n1The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China. 2 Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery andTranslation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province 325035, China. 3Emergency Department, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang Province 318000, China. 4Department of Burns and Skin Repair Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, China. 5 Department of Hepatobiliary and Pancreatic Surgery, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, Zhejiang Province 325000, China. 􀀍 email: [zhw291362263@hotmail.com](zhw291362263@hotmail.com)  \n[www. nature.com/scientificr","cbCaivPxHVzceq2I","https://ap.wps.com/l/cbCaivPxHVzceq2I","pdf",6526962,14,"English","# Background\n## Clinical challenge in breast cancer prognosis\n# ADME-related genes and rationale\n# Methods\n## Data source and gene selection\n## LASSO prognostic signature construction\n## Validation and risk gene expression measurement\n## Nomogram development\n## Immune microenvironment analysis\n# Results and clinical implication","[{\"question\":\"What biological process does the ADME prognostic signature focus on?\",\"answer\":\"It is built on genes involved in drug absorption, distribution, metabolism, and excretion (ADME), reflecting how drug pharmacokinetics may relate to cancer prognosis and response.\"},{\"question\":\"How was the prognostic signature constructed and validated?\",\"answer\":\"The signature was constructed using a least absolute shrinkage and selection operator (LASSO) model on prognostic differentially expressed genes from both cancer tissue and normal tissue, then validated through robustness analyses with RT-qPCR for risk-related gene expression.\"},{\"question\":\"What clinical tool was developed from the ADME signature?\",\"answer\":\"A nomogram was developed by combining clinicopathological characteristics with the four-gene ADME signature to improve clinical utility and predictive performance.\"}]","Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes | PDF",1790022364,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/204dd1be8fcaedd400e9ec4556b1a886.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3a2a8fa6000966d899a6746f54f9f3c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bca4bf377014f103db6d93cb0b599e1.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b799c11082375da789038bb166454860.webp",980,1287]